A Study to Evaluate the Effects of Single Dose of Intravenous Dexmedetomidine on Hyperbaric Bupivacaine

Authors

  • Madiha Shadab Senior Resident, Department of Anesthesia and Critical Care, Patna Medical College and Hospital, Patna, Bihar, India
  • Shafqat Arfin Associate Professor, Department of Anesthesia and Critical Care, Patna Medical College and Hospital, Patna, Bihar, India
  • Rekha Kumari Senior Resident, Department of Anesthesia and Critical Care, Patna Medical College and Hospital, Patna, Bihar, India

Keywords:

Bupivacaine, dexmedetomidine, spinal anaesthesia, below umbilical surgery

Abstract

Aim : The present study was designed to evaluate the effects of single bolus dose of intravenous Dexmedetomidine on spinal anaesthesia and analgesia in patients undergoing below umbilical surgeries with 0.5% Hyperbaric Bupivacaine. Methods: Sixty patients posted for below umbilical surgeries were randomly allocated to two groups. Group D - single bolus dose of 0.5mcg/kg of Dexmedetomidine and Group C - 100 ml of normal saline. Variation in the sensorimotor parameters, effect on sedation and side effects were recorded. Results: The onset of sensory and motor block was significantly earlier in Group D (2.20 ± 0.80 min, 2.17±0.53 min) as compared to Group C (4.33 ± 0.84 min, 3.87 ± 0.62 min). Sedation score and incidence of bradycardia was high in Group D when compared to Group C. Conclusion: Single bolus dose of IV Dexmedetomidine prior to spinal anaesthesia prolongs the duration of sensory block and duration of analgesia with satisfactory arousable sedation and acceptable side effects.

Downloads

Published

2021-10-01

How to Cite

Madiha Shadab, Shafqat Arfin, & Rekha Kumari. (2021). A Study to Evaluate the Effects of Single Dose of Intravenous Dexmedetomidine on Hyperbaric Bupivacaine. International Journal of Health and Clinical Research, 4(17), 55–57. Retrieved from https://ijhcr.com/index.php/ijhcr/article/view/2763

Most read articles by the same author(s)